Acarix AB ACARIX

Acarix AB (publ) today announced the publication of a peer-reviewed study in PLOS Digital Health showing that the seismocardiography (SCG) technology at the heart of its CE-marked, FDA-cleared CADScor®System can also detect heart failure (HF), a condition distinct from the coronary artery disease (CAD) the device is currently indicated for.

Acarix AB (ACIXF) reports robust Q2 2026 results with US revenue up 223%, UAE market entry, and key progress toward CPT1 reimbursement transition.

Acarix will launch the CADScor system in the UAE through UniTech Solutions, which will manage regional distribution.

Acarix AB (publ) today announced that the CADScor® System has received regulatory approval from the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP), clearing the way for commercial availability of the technology across the United Arab Emirates.

As European markets navigate the complexities of geopolitical tensions and inflationary pressures, investors are increasingly exploring diverse opportunities across various sectors. Penny stocks, a term that may sound outdated, still represent a vibrant area for potential growth. These smaller or newer companies can offer significant returns when they possess strong balance sheets and solid fundamentals, providing an attractive option for those looking to uncover hidden value in today's...

European markets have experienced volatility recently, with the pan-European STOXX Europe 600 Index reaching a new high but ending the week nearly flat. As investors navigate these fluctuations, penny stocks continue to capture attention for their potential to offer value and growth that larger firms may overlook. Despite being considered an outdated term, penny stocks represent smaller or newer companies that can provide significant opportunities when backed by strong financials.

Acarix today announced its CADScor®System has successfully achieved certification under the European Union Medical Device Regulation (EU MDR 2017/745).

As December 2025 unfolds, the European markets are showing a mix of cautious optimism and strategic anticipation, with the pan-European STOXX Europe 600 Index posting modest gains amid hopes for interest rate cuts in major economies like the U.S. and UK. In this climate of economic recalibration, investors are increasingly looking towards opportunities that might offer both stability and growth potential. Penny stocks, although an older term, continue to represent a fascinating segment of the...

As the European market navigates a mixed landscape with major stock indexes showing varied performance, investors are keeping a close eye on opportunities that may arise from current economic conditions. Penny stocks, often associated with smaller or newer companies, continue to offer intriguing prospects despite their somewhat outdated moniker. These stocks can provide an affordable entry point into the market and potential growth when backed by strong financials. In this article, we explore...